Redcare Pharmacy N.v. · XETR:RDC
Redcare Pharmacy — Q3 2021 Earnings Presentation
24 slides from Redcare Pharmacy's earnings presentation, Nov 2, 2021
Slide 1: Q3 2021 Earnings Call Presentation
Q3 2021 EARNINGS CALL PRESENTATION. SEVENUM, 2 NOVEMBER 2021
Slide 2: Welcome to Europe's leading customer-centric e-pharmacy platform
2 Q3 EARNINGS CALL. WELCOME TO EUROPE‘S LEADING CUSTOMER-CENTRIC E-PHARMACY PLATFORM. JASPER EENHORST, CFO. STEFAN FELTENS, CEO.
Slide 3: Breaking news on e-Rx: first e-prescriptions processed
3 BREAKING NEWS ON E-RX. THURSDAY, 28 OCTOBER 2021: FIRST E-PRESCRIPTIONS RECEIVED AND SUCCESSFULLY PROCESSED.
Slide 4: Update on e-Rx
4 UPDATE ON E-RX. • GEMATIK E-RX PILOT SCALED UP AND EXTENDED UNTIL END OF NOVEMBER. • COVERAGE OF TECHNICAL REQUIREMENTS – CONNECTORS, E-HBAs, PHYSICIAN / PHARMACY SOFTWARE SYSTEMS – EXPANDING QUICKLY. • NO „BIG BANG“ ON JANUARY 1 BUT GRADUAL E-RX ADOPTION OVER COMING MONTHS. ALREADY RECEIVED AND S
Slide 5: Update on logistics: ready for e-Rx
5 UPDATE ON LOGISTICS. READY FOR E-RX. PROCESS AND SHIP MORE THAN 100,000 PARCELS A DAY.
Slide 6: Presenting you our next-generation logistics centre
6 PRESENTING YOU OUR NEXT- GENERATION LOGISTICS CENTRE.
Slide 7: Update on logistics
7 UPDATE ON LOGISTICS. • MOVE TO OUR NEW LOGISTICS CENTRE FULLY COMPLETED IN EARLY SEPTEMBER THIS YEAR. • PREVIOUS CAPACITY CONSTRAINTS RESOLVED. • SHORTAGE OF LOGISTICS PERSONNEL SUCCESSFULLY ADDRESSED. RETURNING TO OUR GROWTH TRAJECTORY.
Slide 8: Financial performance
wtigy SHOP APOTHEKE FINANCIAL ae PERFORMANCE.
Slide 9: Key facts / 9 months
9 KEY FACTS / 9 MONTHS. • SUSTAINED GROWTH AFTER 9 MONTHS. SALES INCREASE 9.8% TO EUR 772.3M; DACH UP 4.5%, INTERNATIONAL UP 38%. • ADJ. EBITDA EUR 4.7M. KEY FACTS ADJ. EBITDA MARGIN 0.6%. Q2 • STRONG CUSTOMER GROWTH. YEAR OVER YEAR INCREASE ACTIVE CUSTOMERS BASE 1.4M TO 7.3M. 2021 • CUSTOMER SATISF
Slide 10: Key financials: both segments with continued growth
10 KEY FINANCIALS. BOTH SEGMENTS WITH CONTINUED GROWTH. DACH UP 4.5%; INTERNATIONAL UP 38%. 9M TOTAL SHOP APOTHEKE 9M DACH 9M INTERNATIONAL EUROPE sales | vs. prior year sales | vs. prior year sales | vs. prior year in millions of euros in millions of euros in millions of euros +4.5% +9.8% Non-Rx: +
Slide 11: Customer base growing strong
11 7.3M ACTIVE CUSTOMERS. CUSTOMER BASE GROWING STRONG. Number of active customers in million +1.4M 7.3M NET PROMOTER SCORE (NPS). (9M 2020: 70) 68 5.9M EUR Q3 2020 Q3 2021 AVERAGE SHOPPING BASKET VALUE. (9M 2020: EUR 65.84) 61.98
Slide 12: Customer satisfaction on high level again
12 BACK ON TRACK. CUSTOMER SATISFACTION ON HIGH LEVEL AGAIN. Weekly NPS development 75 2021 70 65 Weekly NPS 60 s 01-13 14-26 27-39 55 71 65 67 NPS score 50 Q1 Q2 Q3 Source: SHOP APOTHEKE EUROPE.
Slide 13: Web traffic: growth +30% after purposeful slowdown
13 WEB TRAFFIC. GROWTH +30% AFTER PURPOSEFUL SLOWDOWN MID-YEAR. Weekly website visits 8,000,000 140% (desktop & mobile) 7,000,000 120% 6,000,000 100% 5,000,000 80% 4,000,000 60% 3,000,000 40% Growth year-over- 2,000,000 20% year (%) 1,000,000 0% Total traffic number -20% 01-2021 48-2020 36-2020 24-2
Slide 14: Shop-apotheke.com most popular online pharmacy in Germany
14 WEB TRAFFIC. SHOP-APOTHEKE.COM MOST POPULAR ONLINE PHARMACY TODAY‘S AGENDA IN GERMANY. SOURCE: SIMILARWEB, 30. SEPTEMBER 2021.
Slide 15: Shop-Apotheke most searched pharmacy brand
15 GOOGLE ANALYTICS: SHOP-APOTHEKE. MOST SEARCHED PHARMACY BRAND TODAY‘S AGENDA IN GERMANY. SOURCE: GOOGLE ANALYTICS 2021.
Slide 16: More than 14M orders processed YTD
16 80%+ OF ORDERS FROM RETURNING CUSTOMERS. MORE THAN 14M ORDERS PROCESSED YTD. Number of orders in thousands Share of repeat orders in percentage of total Source: SHOP APOTHEKE EUROPE.
Slide 17: Key financials: EUR 772M sales and EUR 4.7M adj. EBITDA
17 KEY FINANCIALS. EUR 772M SALES AND EUR 4.7M ADJ. EBITDA. Adjusted numbers in millions of euros 9M 2021 YTD vs. 9M 2020 Q3 Q3 2021 vs. Q3 2020 better/ better/ 9M 2020 9M 2021 Q3 2020 Q3 2021 (worse) (worse) Sales 703.3 772.3 9.8% 238.7 237.9 (0.3%) Gross profit margin 22.3% 25.4% 3.1pp 21.9% 25.0%
Slide 18: Gross margin up 3.1 percentage points
18 9M KEY FINANCIALS. GROSS MARGIN UP 3.1 PERCENTAGE POINTS. Gross profit margin 1.7% in percentage of sales 1.3% 0.4% (0.3)% 25.4% 22.3% Net Pricing/ Country/ Other and 9M 2020 Sourcing 9M 2021 Product Mix Rx-OTC Mix Acquisitions Footnote
Slide 19: Selling & distribution up 4.2 percentage points
19 9M KEY FINANCIALS. SELLING & DISTRIBUTION UP 4.2 PERCENTAGE POINTS. Selling & distribution costs in percentage (0.7%) of sales (0.5%) (0.6%) (2.4%) (21.7%) (17.5%) Shipping, Operational Other and 9M 2020 Marketing Packaging and 9M 2021 Labour Acquisitions Payments
Slide 20: Solid cash position
20 KEY FINANCIALS. SOLID CASH POSITION. 315 OPERATING CASH: +EUR 28 MILLION. Positive EBITDA and working capital improvements. 232 128 1 27 (73) INVESTMENTS: EUR 73 MILLION. Smartpatient, MedApp, new logistics centre in NL, regular IT and PP&E. FINANCING: EUR +232 MILLION. Successful convertible bon
Slide 21: Financial guidance
21 FINANCIAL GUIDANCE. • LONG-TERM TARGET PROFITABILITY UNCHANGED: IN EXCESS OF +6% EBIT. • GUIDANCE FOR 2021 • SALES GROWTH GUIDANCE FOR THE FULL YEAR NARROWED DOWN TO THE LOWER END OF THE RANGE TO AROUND 10%. • ADJUSTED EBITDA MARGIN GUIDANCE FOR THE FULL YEAR NARROWED DOWN TO -1% (-10M) • CAPEX E
Slide 22: Time to ask questions
TIME TO ASK QUESTIONS. wtigy SHOP APOTHEKE
Slide 23: Q&A session
23 Q&A SESSION. FEEL FREE TO ASK QUESTIONS... PLEASE MUTE THE WEBCAST. DIAL IN FROM YOUR PHONE. LOCATIONS. PHONE NUMBERS. GERMANY, Frankfurt +49 (0) 69 2222 2018 UK, LOCAL +44 (0) 33 03 36 94 34 USA, Los Angeles +1 323-794-2093 Confirmation Code: 5155882 Press * 1 to ask questions.
Slide 24: Thank you for your time
aig; SHOP APOTHEKE THANK YOU FOR YOUR TIME.